HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PRCT
Procept BioRobotics Corp
Healthcare Medical Devices · California, USA · Reports in usd
Market Cap: $1.36B
Market Cap
$1.36B
Enterprise Val
$1.15B
P/E Ratio
-14.24
P/B Ratio
3.72
Trailing PEG (1Y)
-0.25
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$365.9M
Gross Margin60.63%
Profit Margin60.63%
Return on Equity-25.13%
Return on Assets-18.63%
Current Ratio6.85
Debt/Equity0.21
LT Debt/Equity0.21
Revenue Per Share1.37

Income Statement

Dec 31, 2025
Revenue$76.4M
Cost of Revenue$30.1M
Gross Profit$46.3M
R&D$19.1M
SG&A$58.3M
Operating Expenses$77.4M
Operating Income-$31.0M
Interest Expense-$11.2M
Tax Expense$190.0K
Net Income-$29.8M
EPS (Basic)$-0.53
EPS (Diluted)$-0.53
EBIT-$40.8M
EBITDA-$39.2M
Consolidated Income-$29.8M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$286.5M
Accounts Receivable$83.5M
Inventory$70.7M
Current Assets$450.4M
LT Investments$3.0M
Property, Plant & Equipment$47.9M
Intangibles$709.0K
Non-Current Assets$57.7M
Total Assets$508.1M
Accounts Payable$17.3M
Current Debt$2.2M
Current Liabilities$65.8M
LT Debt$76.3M
Non-Current Liabilities$76.4M
Total Liabilities$142.2M
Total Debt$78.5M
Retained Earnings-$641.6M
Shareholder Equity$365.9M
Shares Outstanding55,878,589

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$10.3M
Investing Cash Flow-$1.9M
Financing Cash Flow$4.4M
CapEx-$1.9M
Free Cash Flow-$12.2M
Depreciation & Amort.$1.6M
Stock-Based Comp$10.8M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$4.4M
Dividends Paid$0.00
Net Change in Cash-$7.8M
Data cached · Meta live · Daily live · Statements live · TTL 24h